| 生物活性 |
Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycolylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research.
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 分子式 |
C24H22F3N
|
||||||||||||
| 分子量 |
381.433396816254
|
||||||||||||
| CAS号 |
428863-50-7
|
||||||||||||
| 中文名称 |
(2S)-1-((2S)-6-氨基-2-((羟基(4-苯基丁基)膦)氧基)己酰基)吡咯烷-2-羧酸
|
||||||||||||
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
||||||||||||
| 储存方式 |
|
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet